Secukinumab Market

Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.
Secukinumab Market contains market size and forecasts of Secukinumab in global, including the following market information:
Global Secukinumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Secukinumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Secukinumab companies in 2021 (%)
The global Secukinumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Secukinumab include Carbosynth, TargetMol Chemicals, Changzhou Chenhong Biotechnology, DC Chemicals, Huatesheng Biotechnology, Hubei Guangao Biotechnology, Hubei Kele Fine Chemical, Hubei Widely Chemical Technology and Hubei Xingcheng Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Secukinumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Secukinumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Secukinumab Market Segment Percentages, by Type, 2021 (%)
Patent
Generic
Global Secukinumab Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Secukinumab Market Segment Percentages, by Application, 2021 (%)
Chemical
Pharmaceutical
Global Secukinumab Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Secukinumab Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Secukinumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Secukinumab revenues share in global market, 2021 (%)
Key companies Secukinumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Secukinumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Carbosynth
TargetMol Chemicals
Changzhou Chenhong Biotechnology
DC Chemicals
Huatesheng Biotechnology
Hubei Guangao Biotechnology
Hubei Kele Fine Chemical
Hubei Widely Chemical Technology
Hubei Xingcheng Biotechnology
Hubei Zhongshan Medical Technology
Jiangxi Ruiweier Biotechnology
Nantong Hi-Future Biotechnology
Shanghai Biochempartner
Shanghai Minkai Biotechnology
Shanghai Yifei Biotechnology
Shanghai Yu'ang Chemical
Sichuan Weiqi Biotechnology
Taizhou KEDE Chemical
WeiShi Reagent
Wuhan Dingxintong Pharmaceutical
Wuhan Fortuna Chemical
Wuhan Topule Biopharmaceutical
Wuhan Weisman Bioengineering
Wuhan Yingnuo Pharmaceutical Technology